Takeda Pharmaceutical (TAK) Short term Debt (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Short term Debt of $27.7 billion for Q2 2026, down 2.96% year-over-year from $28.6 billion in Q2 2025, and little changed quarter-over-quarter from $27.9 billion in Q1 2026.
Takeda Pharmaceutical (TAK) Short term Debt (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Short term Debt history runs 9 years deep, the most recent figure standing at $27.7 billion for Q2 2026.
- In Q2 2026, Short term Debt fell 2.96% year-over-year to $27.7 billion; the TTM figure through Jun 2026 stood at $27.7 billion (down 2.96% YoY), while the FY2026 annual figure was $29.0 billion, up 705.52% from the prior year.
- Short term Debt for Q2 2026 stood at $27.7 billion, roughly flat from $27.9 billion in the prior quarter.
- The five-year high for Short term Debt was $33.4 billion in Q2 2022, with the low at $1.8 billion in Q1 2022.
- The 5-year median for Short term Debt is $28.8 billion (2023), against an average of $23.7 billion.
- The sharpest annual moves came in 2022 and 2026: Short term Debt retreated 25.57% in 2022, then soared 674.4% in 2026.
- Takeda Pharmaceutical's Short term Debt stood at $27.7 billion in 2022, then climbed by 4.83% to $29.0 billion in 2023, then increased by 6.53% to $30.9 billion in 2024, then decreased by 10.34% to $27.7 billion in 2025, then retreated by 0.06% to $27.7 billion in 2026.
- Business Quant data shows TAK's Short term Debt at $27.7 billion in Q2 2026, $27.9 billion in Q1 2026, and $27.7 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.73 Bn |
| Mar 31, 2026 | 27.86 Bn |
| Dec 31, 2025 | 27.75 Bn |
| Sep 30, 2025 | 29.53 Bn |
| Jun 30, 2025 | 28.58 Bn |
| Mar 31, 2025 | 3.60 Bn |
| Dec 31, 2024 | 30.95 Bn |
| Sep 30, 2024 | 29.68 Bn |
| Jun 30, 2024 | 32.39 Bn |
| Mar 31, 2024 | 2.48 Bn |
| Dec 31, 2023 | 29.05 Bn |
| Sep 30, 2023 | 30.50 Bn |
| Jun 30, 2023 | 31.60 Bn |
| Mar 31, 2023 | 2.57 Bn |
| Dec 31, 2022 | 27.71 Bn |
| Sep 30, 2022 | 30.18 Bn |
| Jun 30, 2022 | 33.41 Bn |
| Mar 31, 2022 | 1.76 Bn |
| Dec 31, 2021 | 37.23 Bn |
| Sep 30, 2021 | 36.49 Bn |